Published in Br J Pharmacol on November 01, 1991
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax (1993) 1.70
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis (2014) 1.34
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax (1993) 1.22
Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax (1995) 1.19
Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol (2006) 1.17
Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Br J Pharmacol (1993) 1.12
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. Br J Clin Pharmacol (2015) 1.10
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax (2000) 1.06
Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol (1995) 1.03
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue. Br J Pharmacol (1993) 1.01
Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol (1993) 0.99
Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol. Br J Pharmacol (2009) 0.97
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol (1991) 0.96
The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br J Pharmacol (1994) 0.96
Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure. Br J Pharmacol (2009) 0.95
Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha). Br J Pharmacol (2001) 0.95
Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax (1994) 0.95
Drugs for asthma. Br J Pharmacol (2006) 0.94
Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol (1992) 0.90
Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br J Pharmacol (1996) 0.89
Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues. Br J Pharmacol (1996) 0.89
Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol (1993) 0.86
Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line. Br J Pharmacol (1993) 0.85
Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in bovine trachealis muscle: studies of mechanical activity and ion fluxes. Br J Pharmacol (1993) 0.85
Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol (1994) 0.85
Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea. Br J Pharmacol (1995) 0.82
Inhalation of beta 2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract. Respir Res (2006) 0.81
Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter. Br J Pharmacol (1994) 0.80
Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma. Thorax (1997) 0.80
Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation. Mol Cells (2014) 0.79
Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation. Br J Pharmacol (1996) 0.79
Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol. Thorax (1996) 0.79
Pharmacotherapies for COPD. Clin Med Insights Circ Respir Pulm Med (2013) 0.79
Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma. Respir Res (2015) 0.78
Airway smooth muscle relaxation. Thorax (1995) 0.78
Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues. Br J Pharmacol (1999) 0.78
Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle. Br J Pharmacol (1995) 0.78
GPCR endocytosis confers uniformity in responses to chemically distinct ligands. Mol Pharmacol (2016) 0.77
Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways. Br J Pharmacol (1995) 0.77
Treatment of mild chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 0.77
Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol. Physiol Rep (2016) 0.75
Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo. Br J Clin Pharmacol (2016) 0.75
Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat. Br J Pharmacol (1996) 0.75
Sir David Jack: an extraordinary drug discoverer and developer. Br J Clin Pharmacol (2013) 0.75
Long-acting beta 2-agonists. Role in primary care asthma treatment. Can Fam Physician (1997) 0.75
Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro. Exp Brain Res (1997) 0.75
Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers. Inflammation (2007) 0.75
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
Evidence for nonadrenergic inhibitory nerves in the guinea pig trachealis muscle. Am J Physiol (1973) 2.91
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax (1988) 2.40
Analysis of the effects of changes in rate and rhythm upon myocardial contractility. J Pharmacol Exp Ther (1961) 2.17
The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists. Eur J Pharmacol (1984) 1.85
Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'? Trends Pharmacol Sci (1990) 1.82
Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy (1985) 1.46
Bronchodilator drugs. Pharmacol Ther (1982) 1.39
Aerosolized bronchodilators and steroids in the treatment of airway obstruction in adults. Am Rev Respir Dis (1980) 1.38
Novel and versatile superfusion system. Its use in the evaluation of some spasmogenic and spasmolytic agents using guinea-pig isolated tracheal smooth muscle. J Pharmacol Methods (1989) 1.19
Annals of allergy. Ann Allergy (1975) 1.17
Choice of drug treatment in asthma. Pharmacol Ther (1982) 1.00
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (2000) 6.98
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
A testing time for doctors: counselling patients before an HIV test. BMJ (1991) 5.14
GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (1998) 5.03
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J (1978) 4.99
Does tobacco advertising target young people to start smoking? Evidence from California. JAMA (1991) 4.63
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol (1969) 3.86
Glycogen storage disease in adults. Ann Intern Med (1994) 3.58
Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature (1968) 3.48
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res (2000) 3.42
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 3.37
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA (2001) 3.28
Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem (1980) 3.06
Memory interference during language processing. J Exp Psychol Learn Mem Cogn (2001) 2.92
Women prefer hospital births. BMJ (1992) 2.88
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol (1976) 2.82
Immunocytochemical localization of phytochrome. Proc Natl Acad Sci U S A (1971) 2.81
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res (1994) 2.75
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet (2003) 2.72
Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol (1997) 2.72
New class of selective stimulants of beta-adrenergic receptors. Nature (1968) 2.72
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
American College of Sports Medicine position stand. The Female Athlete Triad. Med Sci Sports Exerc (1997) 2.61
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58
Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J Physiol (1967) 2.47
AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J (1999) 2.46
First-year impact of the 1989 California cigarette tax increase on cigarette consumption. Am J Public Health (1992) 2.42
Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med (2008) 2.31
Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1990) 2.27
An immunochemical characterization of the phytochrome destruction reaction. Biochim Biophys Acta (1974) 2.20
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Implantation of electrodes in the dentine of an upper canine tooth in the dog. Br J Pharmacol (1971) 2.18
Estimates of population smoking prevalence: self-vs proxy reports of smoking status. Am J Public Health (1994) 2.16
Centromere-linkage analysis and consolidation of the zebrafish genetic map. Genetics (1996) 2.15
Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem (2000) 2.14
The relationship among television watching, physical activity, and body composition of young children. Pediatrics (1994) 2.13
Fluorescence lifetime imaging. Anal Biochem (1992) 2.08
Counselling patients before an HIV test. BMJ (1991) 2.08
Protection from environmental tobacco smoke in California. The case for a smoke-free workplace. JAMA (1992) 2.06
The intracerebral effects of noradrenaline and its modification by drugs in the mouse. J Pharm Pharmacol (1966) 2.06
Brief report: Chlamydia psittaci endocarditis diagnosed by blood culture. N Engl J Med (1992) 2.05
Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry (1999) 2.04
Patient characteristics and environmental factors in leg ulcer healing. J Wound Care (1995) 2.03
Infertility among human immunodeficiency virus-positive women: incidence and treatment dilemmas. Hum Reprod (1996) 2.01
Reversible redistribution of phytochrome within the cell upon conversion to its physiologically active form. Proc Natl Acad Sci U S A (1975) 2.01
Clinical implications of endoscopic ultrasound: the American Endosonography Club Study. Gastrointest Endosc (1996) 1.98
A non-adrenergic inhibitory nervous pathway in guinea-pig trachea. Br J Pharmacol (1974) 1.97
Biosonar performance of foraging beaked whales (Mesoplodon densirostris). J Exp Biol (2005) 1.96
The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy (1973) 1.96
A method to produce sedation in critically ill patients. Ann Pharmacother (1996) 1.96
The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem (1999) 1.93
Lateral diffusion in plasma membrane of mouse egg is restricted after fertilisation. Nature (1978) 1.90
Age at natural menopause and risk of cardiovascular disease. Arch Intern Med (1999) 1.90
The metabolism of salbutamol in man. Xenobiotica (1973) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Selective changes in microsomal enzymes of triacylglycerol phosphatidylcholine, and phosphatidylethanolamine biosynthesis during differentiation of 3T3-L1 preadipocytes. J Biol Chem (1978) 1.86
How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery. J Glaucoma (2001) 1.83
Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology (1989) 1.81
Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav (2000) 1.81
Cross-age tutoring: fifth graders as arithmetic tutors for kindergarten children. J Appl Behav Anal (1974) 1.79
HIV seroprevalence in a London same-day testing clinic. AIDS (1994) 1.78
Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol (1976) 1.77
Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus. Virology (1998) 1.77
Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers". Proc Natl Acad Sci U S A (1988) 1.76
Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol (1979) 1.76
Energized endocytosis in human erythrocyte ghosts. J Clin Invest (1975) 1.74
Men making sense of their chest pain--niggles, doubts and denials. J Clin Nurs (2000) 1.73
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
Impaired auditory recognition of fear and anger following bilateral amygdala lesions. Nature (1997) 1.73
What is the daily practice of mechanical ventilation in pediatric intensive care units? A multicenter study. Intensive Care Med (2004) 1.69
The nature of fatigue in multiple sclerosis. J Psychosom Res (1998) 1.67
Problem drug use in a central London general practice. BMJ (1992) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem (2001) 1.64
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J Biol Chem (2001) 1.64
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Face processing impairments after amygdalotomy. Brain (1995) 1.63
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother (1998) 1.62
Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem (1999) 1.62
Do women with HIV infection consult with their GPs? Br J Gen Pract (1998) 1.62
On the assessment of stability and patterning of speech movements. J Speech Lang Hear Res (2000) 1.62
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons. J Infect Dis (2001) 1.62